TransMedics Group, Inc.
TMDX
$68.94
$0.090.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 173.93M | 160.76M | 143.82M | 157.37M | 143.54M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 173.93M | 160.76M | 143.82M | 157.37M | 143.54M |
| Cost of Revenue | 72.77M | 67.35M | 59.25M | 60.78M | 55.31M |
| Gross Profit | 101.16M | 93.41M | 84.58M | 96.59M | 88.23M |
| SG&A Expenses | 62.99M | 51.44M | 46.02M | 44.09M | 43.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 160.64M | 139.49M | 120.52M | 120.80M | 116.09M |
| Operating Income | 13.30M | 21.27M | 23.30M | 36.57M | 27.44M |
| Income Before Tax | 8.49M | 21.63M | 23.03M | 36.18M | 26.68M |
| Income Tax Expenses | 1.17M | -83.75M | -1.29M | 1.28M | 994.00K |
| Earnings from Continuing Operations | 7.32M | 105.38M | 24.32M | 34.91M | 25.68M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.32M | 105.38M | 24.32M | 34.91M | 25.68M |
| EBIT | 13.30M | 21.27M | 23.30M | 36.57M | 27.44M |
| EBITDA | 24.46M | 28.24M | 29.35M | 43.30M | 33.58M |
| EPS Basic | 0.21 | 3.08 | 0.71 | 1.03 | 0.76 |
| Normalized Basic EPS | 0.15 | 0.40 | 0.42 | 0.67 | 0.49 |
| EPS Diluted | 0.20 | 2.58 | 0.66 | 0.92 | 0.70 |
| Normalized Diluted EPS | 0.15 | 0.33 | 0.35 | 0.56 | 0.42 |
| Average Basic Shares Outstanding | 34.38M | 34.22M | 34.11M | 33.91M | 33.72M |
| Average Diluted Shares Outstanding | 36.19M | 40.93M | 40.75M | 40.56M | 39.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |